Cholesterol & Lipid
Sort by:
Cardiovascular Atherosclerosis: Prediction, Prevention and Management
Update on Inflammation and Novel Biomarkers for Atherosclerosis
FEATURING
Douglas Triffon
- 382 views
- August 11, 2021
- 2
1st Women’s Heart and Vascular Symposium
Women and Peripheral Arterial Disease
FEATURING
Georges Nseir
- 372 views
- January 20, 2020
- 2
Canadian Collaborative Research Network
CV Medicine in the Next Decade: Predicting the Future
FEATURING
Deepak Bhatt
- 365 views
- June 13, 2022
- 2
ASPC 2019 Congress on CVD Prevention
2019 Prevention Guidelines: Applying the Guidelines to Practice
FEATURING
Salim Virani
- 365 views
- August 12, 2019
- 3
National Lipid Association
Lipids Clinic Management in Private Practice Setting
FEATURING
Ann Liebeskind
- 359 views
- March 25, 2019
- 2
National Lipid Association
Is Noninvasive Imaging Ready for Prime Time to Assist in the Medical Management of Children with Dyslipidemia?
FEATURING
Elaine Urbina
- 358 views
- March 25, 2019
- 1
Houston Methodist DeBakey Heart and Vascular Center
Management of Atherosclerotic Extracranial Carotid Disease: Carotid Endarterectomy Vs. Stenting
FEATURING
Alpesh Shah
- 357 views
- October 29, 2021
- 1
Precision Cardiovascular Care 2024: Transitioning Care from Phenotypes to Genotypes
Lipoprotein(a) in 2024
FEATURING
Harpreet Bhatia
- 352 views
- May 17, 2024
- 6
ACC 2024 Insights
ACC 2024 Insights: Plozasiran (ARO-APOC3), An Investigational RNAi Therapeutic, Demonstrates Profound and Durable Reductions In APOC-3 and Triglycerides (TG) in Patients With Severe Hypertriglyceridemia (SHTG), SHASTA-2 Final Results
FEATURING
Daniel Gaudet
- 351 views
- April 16, 2024
- 3
Scripps Health
Familial Hypercholesterolemia: From Diagnosis to Treatment
FEATURING
P. Barton Duell
- 339 views
- June 28, 2023
- 3
The Texas Heart Institute
Cariology and Cardiology: Chronic Disease and the Toxic Food Environment
FEATURING
Robert Lustig
- 335 views
- March 10, 2023
- 2
Houston Methodist DeBakey Heart and Vascular Center
Managing Cholesterol: Statins and Beyond
FEATURING
Peter Howard Jones
- 333 views
- July 13, 2019
- 1
ASPC 2018 Congress on CVD Prevention
Debate – Con – Lipoprotein(a) – There is Nothing You Can Do About It So Why Measure?
FEATURING
Sergio Fazio
- 333 views
- August 10, 2018
- 1
ASPC 2018 Congress on CVD Prevention
Coronary Risk Assessment in Women: What Works?
FEATURING
Martha Gulati
- 329 views
- August 10, 2018
- 1
National Lipid Association
Evidence-Based Therapy for the Cardiometabolic Syndrome. Can We Level the Metabolic Playing Field?
FEATURING
Michele Mietus-Snyder
- 328 views
- March 25, 2019
- 1
The American Society for Preventive Cardiology
Accessing Breakthrough Cholesterol Treatments
FEATURING
Seth Baum
- 326 views
- March 20, 2018
- 1
Houston Methodist DeBakey Heart and Vascular Center
Predicting Progression of CVD and Cognitive Dysfunction in Childhood, Midlife and Elderly: When and Where Does the Atherosclerosis Start? How to Use Multimodality Imaging to Predict Plaque Progression?
FEATURING
Valentin Fuster
- 325 views
- March 26, 2021
- 2
University of Colorado Department of Medicine
Evaluating and Treating "Residual Risk" in ASCVD
FEATURING
Michael Blaha
- 324 views
- November 26, 2022